CTSO
Cytosorbents Corp
Price:  
1.00 
USD
Volume:  
136,872.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO WACC - Weighted Average Cost of Capital

The WACC of Cytosorbents Corp (CTSO) is 8.1%.

The Cost of Equity of Cytosorbents Corp (CTSO) is 8.20%.
The Cost of Debt of Cytosorbents Corp (CTSO) is 7.00%.

Range Selected
Cost of equity 6.10% - 10.30% 8.20%
Tax rate 3.40% - 4.20% 3.80%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.2% - 10.0% 8.1%
WACC

CTSO WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.43 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 10.30%
Tax rate 3.40% 4.20%
Debt/Equity ratio 0.1 0.1
Cost of debt 7.00% 7.00%
After-tax WACC 6.2% 10.0%
Selected WACC 8.1%